GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Shelter Pharma Ltd
Shelter Pharma Board Approves Regularization of Independent Director
BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 01 Sep 2026, 02:33 PM IST  ·  BSE ID: fe3f70c2-a692-46e6-9cbe-343459667621
View Original BSE Filing (PDF)
💡
In Simple Terms
Shelter Pharma's directors met and confirmed Ms. Gadhavi as an independent director for five years and reappointed Mrs. Idariya.
🤖 AI Summary
  • Board approved regularization of Vinita Gadhavi as Non-Executive Independent Director.
  • Director Gadhavi's term is for five years, effective July 31, 2026, to July 30, 2031.
  • Approved ratification of material related party transactions for FY2025-26.
  • Approved material related party transactions planned for FY2026-27.
  • Re-appointment of Mrs. Parvezbanu Idariya as a Director was also approved.
🏢 How This Affects the Company
⚙️
Operational Impact
The regularization of Ms. Vinita Gadhavi as an Independent Director and the re-appointment of Mrs. Parvezbanu Idariya will continue established board governance.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time, as the regularization is subject to shareholder approval at the ensuing AGM.
👤
Who Is Affected
All shareholders will be affected by decisions regarding board composition and related party transactions that ensure corporate governance.
🔍
Management Signal
Management is prioritizing governance continuity and adherence to regulatory requirements for director appointments and related party dealings.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder approval for director regularization at the upcoming AGM.
Disclosure of finalized material related party transactions for FY2026-27.
Next quarterly financial results disclosure.
LOW RISK The filing concerns routine board meeting outcomes and director appointments.
💡 Investor Takeaway
Shelter Pharma's board regularized Ms. Vinita Gadhavi as an independent director for five years and approved related party transactions for FY2026-27.
⚖️ Strengths & Concerns

✅ Positives

  • Board approval for regularization of Independent Director ensures continued governance oversight.
  • Ratification of past and approval of future related party transactions provides clarity on inter-company dealings.
❓ Frequently Asked Questions
When was Ms. Vinita Shivraj Gadhavi regularized as an Independent Director at Shelter Pharma?
Ms. Vinita Shivraj Gadhavi was regularized as a Non-Executive Independent Director for a term of five consecutive years, effective from 31st July, 2026.
What is the term of Ms. Vinita Gadhavi's appointment as an Independent Director?
Ms. Vinita Gadhavi's term as a Non-Executive Independent Director is for five consecutive years, from 31st July, 2026, till 30th July, 2031.
What material transactions were approved by Shelter Pharma's Board?
The Board approved the ratification of material transactions with related parties during FY2025-26 and approved material related party transactions for FY2026-27.
Who else was re-appointed as a Director at Shelter Pharma?
Mrs. Parvezbanu Mohamed Rafiq Idariya was re-appointed as a Director, as she retires by rotation and offers herself for re-appointment.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.